An exploration of knowledge, risk perceptions, and communication in a family with multiple genetic risks for Parkinson's disease
Journal of Genetic Counseling · 2023
DOI: 10.1002/jgc4.1677 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Genetic Counseling, 2023. Verfasst von Emily C Daykin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Parkinson Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Genomic testing increasingly challenges health care providers and patients to understand, share, and use information. The provision of polygenic risks is anticipated to complicate comprehension, communication, and risk perception further. This manuscript aims to illuminate the challenges confronting families with multiple genetic risks for Parkinson's disease. Identifying and planning for such issues may prove valuable to family members now and in the future, should neuroprotective or genotype‐specific therapies become available. We present qualitative data from interviews with a multi‐generational family carrying pathogenic variants in the glucocerebrosidase ( GBA1 ) and leucine‐rich repeat kinase 2 ( LRRK2 ) genes which are associated with an increased risk for developing Parkinson's disease (PD). The family includes two brothers (heterozygous for LRRK2 p.G2019S and homozygous for GBA1 p.N409S) and their four descendants. The brothers were concordant for GD and discordant for PD. Genetic counseling and testing were provided to four of the six participants. Two years later, semi‐structured interviews were conducted with the initial participants ( n = 4) and two additional first‐degree relatives. Interviews were transcribed and thematically analyzed, providing the basis for this report. Illuminated topics include the perceived risk of developing PD, recall of genetic information, and family communication. With the expanding use of exome and genome sequencing, we anticipate that genetic counselors will increasingly face the challenges demonstrated by this case involving multiple genetic risks for PD, limited data to clarify risk, and the inherent variability of family communication, genetic knowledge, and risk perception. This clinical case report provides a compelling narrative demonstrating the need for additional research exploring these multifaceted topics relevant to both families facing these challenges and providers striving to assist, support and guide their journey.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, USA.
- Office of the Clinical Director, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Donald W Hadley
Förderung
- Intramural NIH HHS
Zitieren
APA
Daykin, E. C., Poffenberger, C. N., Do, J., Ryan, E., Tayebi, N., Sidransky, E., Lopez, G., & Hadley, D. W. (2023). An exploration of knowledge, risk perceptions, and communication in a family with multiple genetic risks for Parkinson's disease. Journal of Genetic Counseling. https://doi.org/10.1002/jgc4.1677
Vancouver
Daykin EC, Poffenberger CN, Do J, Ryan E, Tayebi N, Sidransky E, et al. An exploration of knowledge, risk perceptions, and communication in a family with multiple genetic risks for Parkinson's disease. Journal of Genetic Counseling. 2023. doi:10.1002/jgc4.1677
BibTeX
@article{Daykin2023,
author = {Daykin, Emily C and Poffenberger, Chelsie N and Do, Jenny and Ryan, Emory and Tayebi, Nahid and Sidransky, Ellen and Lopez, Grisel and Hadley, Donald W},
title = {An exploration of knowledge, risk perceptions, and communication in a family with multiple genetic risks for Parkinson's disease},
journal = {Journal of Genetic Counseling},
year = {2023},
doi = {10.1002/jgc4.1677}
}
EUVIMED